CHANCE Investigators Selected Research

Pathologic Constriction (Stenosis)

1/2018	High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis.
9/2015	Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

CHANCE Investigators Research Topics

Disease

21	Stroke (Strokes) 01/2024 - 09/2010
16	Transient Ischemic Attack 01/2024 - 09/2010
7	Ischemic Stroke 01/2020 - 07/2013
5	Hemorrhage 01/2023 - 07/2013
2	Pathologic Constriction (Stenosis) 01/2018 - 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Overweight 01/2020
1	Infarction (Infarctions) 01/2020
1	Obesity 01/2020
1	Chronic Renal Insufficiency 12/2018
1	Hyperglycemia 11/2017
1	Diabetes Mellitus 06/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017
1	Hemorrhagic Stroke 07/2013
1	Cerebral Hemorrhage 09/2010

Drug/Important Bio-Agent (IBA)

20	Clopidogrel (Plavix)FDA Link 01/2023 - 09/2010
15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 09/2010
4	AlbuminsIBA 01/2024 - 03/2015
3	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2017
3	C-Reactive ProteinIBA 01/2018 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 09/2010
1	apatinibIBA 12/2023
1	Monoclonal AntibodiesIBA 12/2023
1	camrelizumabIBA 12/2023
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2023
1	HomocysteineIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	CD40 Ligand (CD40L)IBA 07/2015

Therapy/Procedure

15	Therapeutics 01/2024 - 07/2013
1	Secondary Prevention 01/2023
1	Glycemic Control 01/2017